Faculty

Aruna Kamineni

Clinical Assistant Professor, Epidemiology


arunasree.kamineni@gmail.com

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Washington, 1997

Contact


arunasree.kamineni@gmail.com

WA

Bio

Aruna Kamineni, PhD, MPH, has expertise in using case-control methods to evaluate screening efficacy, and her research focuses on addressing evidence gaps for clinical guidelines, particularly for cervical and colorectal cancer prevention. A substantial portion of her work has focused on developing infrastructure and methods for research using electronic clinical and administrative health care data.

Since 2011, Dr. Kamineni has participated in the National Cancer Institute’s Population-based Research to Optimize the Screening Process (PROSPR) consortium to evaluate and improve cancer screening in U.S. community settings. As a principal investigator for multisite cervical and colorectal cancer PROSPR Research Centers, Dr. Kamineni is leading and collaborating on work to determine how to optimally use screening tests and consider how to tailor screening for population subgroups.

Dr. Kamineni’s research goals include studying the impact of human papillomavirus (HPV) DNA testing and HPV vaccination on cervical cancer and screening programs. Multidisciplinary collaboration is a valued and important driver of Dr. Kamineni’s research and she embraces a team science approach to optimizing cancer prevention.

Recent Publications (PubMed)

Timing of Colposcopy and Risk of Cervical Cancer.
(2023 Aug 22)
Obstet Gynecol
Alimena S, Lykken JM, Tiro JA, Chubak J, Kamineni A, Haas JS, Werner C, Kobrin SC, Feldman S

Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds.
(2023 Jul 14)
Cancer Epidemiol Biomarkers Prev
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J

Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems.
(2023 Oct)
Prev Med Rep 35(): 102279
McCarthy AM, Tiro JA, Hu E, Ehsan S, Chubak J, Kamineni A, Feldman S, Atlas SJ, Silver MI, Kobrin S, Haas JS

Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review.
(2023 Apr 11)
J Natl Cancer Inst 115(4): 375-384
Selby K, Sedki M, Levine E, Kamineni A, Green BB, Vachani A, Haas JS, Ritzwoller DP, Croswell JM, Ohikere K, Doria-Rose VP, Rendle KA, Chubak J, Lafata JE, Inadomi J, Corley DA

Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.
(2023 Apr 1)
J Low Genit Tract Dis 27(2): 113-119
Del Vecchio NJ, Beaber EF, Garcia MP, Wheeler CM, Kamineni A, Chao C, Chubak J, Corley DA, Owens CL, Winer RL, Pruitt SL, Raine-Bennett T, Feldman S, Silverberg M

Show complete publication list

In the News

No news articles at this time.